Atlas Trials

Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults

Clinical trial NCT00621322 · COMPLETED

Trial details

NCT number
NCT00621322
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2008-04-03
Primary completion
2009-04-03
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.